What the diabetologist needs to know about the risk of non-arteritic anterior ischaemic optic neuropathy and GLP-1 receptor agonist use in patients with type 2 diabetes
S. Feldman–Billard
Topics & Concepts
MedicineAgonistType 2 diabetesAnterior ischemic optic neuropathyDiabetes mellitusGlucagon-like peptide 1 receptorAnesthesiaInternal medicineReceptorSurgeryOphthalmologyOptic nerveEndocrinologyIntraoperative Neuromonitoring and Anesthetic EffectsGlaucoma and retinal disordersRetinal Diseases and Treatments